Graft SurvivalImmunosuppressive AgentsKidney TransplantationLiver TransplantationGraft RejectionCyclosporineTransplantation, HomologousTacrolimusImmunosuppressionMycophenolic AcidHeart TransplantationOrgan TransplantationBone Marrow TransplantationTissue DonorsAzathioprineSurvival RateIslets of Langerhans TransplantationTreatment OutcomeLung TransplantationPancreas TransplantationTransplantationCyclosporinsTransplantation ImmunologyTime FactorsHematopoietic Stem Cell TransplantationRetrospective StudiesCalcineurinTransplantation, AutologousTransplantation ToleranceSirolimusLiving DonorsCadaverSkin TransplantationCell SurvivalCorneal TransplantationFollow-Up StudiesTissue and Organ ProcurementStem Cell TransplantationPostoperative ComplicationsHistocompatibility TestingTransplantation ConditioningAntilymphocyte SerumSurvival AnalysisAmino Acid IsomerasesTransplantation, HeterotopicT-LymphocytesGraft vs Host DiseaseImmune ToleranceRecurrenceTransplantation, IsogeneicLiver FailureCell TransplantationMice, Inbred C57BLRats, Inbred LewKidney Failure, ChronicDisease-Free SurvivalTransplantation ChimeraPrednisoloneKeratoplasty, PenetratingPropylene GlycolsGraft Occlusion, VascularTransplantsOrgan PreservationDelayed Graft FunctionMice, Inbred BALB CPrednisoneRisk FactorsCold IschemiaTransplantation, HeterologousDrug Therapy, CombinationAntibodies, MonoclonalPolyenesKaplan-Meier EstimateHistocompatibilityCyclophosphamideBrain DeathLymphocyte ActivationIMP DehydrogenasePeptidylprolyl IsomeraseTacrolimus Binding ProteinsFetal Tissue TransplantationCells, CulturedHLA AntigensKidneyCyclophilinsReoperationGraft Enhancement, ImmunologicImmunocompromised HostBiopsyMethylprednisoloneDonor SelectionProspective StudiesSurvivalWaiting ListsIsoantigensAcute DiseasePrimary Graft DysfunctionPrognosisCord Blood Stem Cell TransplantationHeart-Lung Transplantation